4D Pharma (DDDD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 78.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 190.00
  • 52 Week Low: 76.00
  • Currency: UK Pounds
  • Shares Issued: 65.49m
  • Volume: 0
  • Market Cap: 51.09m
  • Beta: 0.01
Select chart: 1 week | 1 month | 3 month | 6 month
 

Current

1 week

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (29.33) (41.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (29.06) (40.60)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
31-Dec-2019 0 0 0 0 0 n/a
31-Dec-2020 0 0 n/a n/a n/a n/a
 
Earnings
31-Dec-2019 n/a n/a n/a n/a n/a n/a
31-Dec-2020 n/a n/a n/a n/a n/a n/a
 
Dividend
31-Dec-2019 n/a n/a n/a n/a n/a n/a
31-Dec-2020 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 1 1 1 1 0
Buy 0 0 0 0 0 0
Neutral 0 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 1 1 1 1 1 0
 
Average Rec 10.00 10.00 10.00 10.00 10.00 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

4D Pharma Market Data

Currency UK Pounds
Share Price 78.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 190.00
52 Week Low 76.00
Volume 0
Shares Issued 65.49m
Market Cap 51.09m
Beta 0.01

4D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
1.74% above the market average1.74% above the market average1.74% above the market average1.74% above the market average1.74% above the market average
11.86% below the sector average11.86% below the sector average11.86% below the sector average11.86% below the sector average11.86% below the sector average
Price Trend
84.67% below the market average84.67% below the market average84.67% below the market average84.67% below the market average84.67% below the market average
70% below the sector average70% below the sector average70% below the sector average70% below the sector average70% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

4D Pharma Dividends

No dividends found

Trades for --2019

Time Volume / Share Price
0 @ 0.000p

4D Pharma Key Personnel

CEO Duncan Joseph Peyton

Top of Page